This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today ...

Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic(R) technology has been licensed by Ginkgo ...

Dutch privately-held company ProteoNic, a provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic technology has been ...

OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...

Materials react differently to electric and magnetic fields, and these reactions are known as electromagnetic responses. In ...

Merchants Fleet and Cognizant are using enterprise AI to update core systems such as billing, maintenance administration, software development, and remarketing to cut cycle times, improve accuracy, ...

Framed around advances in technology, design, product strategy and brand ambition, the event outlined a comprehensive upgrade of the marque.

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

The AV-8B Harrier is now nearly retired—but its mission profile will live on in the F-35B Lightning II, which shares many of the same capabilities.

Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...